[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100649447":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":30,"centralContacts":35,"locations":42,"responsibleParty":60,"collaborators":29,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":29,"eligibilityCriteria":69,"healthyVolunteers":70,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":29,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":84,"overallStatus":44,"whyStopped":29,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"University of Phayao","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Placebo","PLACEBO_COMPARATOR","Participants will receive matching placebo capsules orally once daily for 12 weeks.",[13],"Dietary Supplement: Spirulina capsules",{"label":15,"type":16,"description":17,"interventionNames":18},"Spirulina Blue Protein 200 mg\u002Fday","EXPERIMENTAL","Participants will receive Spirulina Blue Protein capsules at a dose of 200 mg\u002Fday orally once daily for 12 weeks.",[13],{"label":20,"type":16,"description":21,"interventionNames":22},"Spirulina Blue Protein 1000 mg\u002Fday","Participants will receive Spirulina Blue Protein capsules at a dose of 1,000 mg\u002Fday orally once daily for 12 weeks.",[13],[24],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":29},"DIETARY_SUPPLEMENT","Spirulina capsules","Spirulina Blue Protein Capsule",[9,20,15],null,[31],{"name":32,"affiliation":33,"role":34},"Chutamas Thepmalee, PhD","School of Medical Sciences, University of Phayao","PRINCIPAL_INVESTIGATOR",[36,40],{"name":32,"role":37,"phone":38,"phoneExt":29,"email":39},"CONTACT","+66 81 042 9243","th.chutamas@gmail.com",{"name":41,"role":37,"phone":29,"phoneExt":29,"email":39},"Rattapoom Prommana, PhD",[43],{"facility":33,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","Phayao","Changwat Phayao","56000","Thailand","TH",{"type":51,"coordinates":52},"Point",[53,54],99.87883,19.19203,{"lat":54,"lon":53},[57,58],{"name":32,"role":37,"phone":38,"phoneExt":29,"email":39},{"name":41,"role":37,"phone":29,"phoneExt":29,"email":59},"rattapoom.ph@up.ac.th",{"type":34,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":29,"oldOrganization":29},"Chutamas Thepmalee","Associated Professor, School of Medical Sciences","100649447","assessment-of-the-immunomodulatory-potential-of-spirulina-blue-protein-capsule-on-immunomodulation-in-healthy-volunteers-100649447",false,"NCT07733362","Assessment of the Immunomodulatory Potential of Spirulina Blue Protein Capsule on Immunomodulation in Healthy Volunteers","A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Immunomodulatory Potential and Safety of Spirulina Blue Protein Capsules in Healthy Volunteers","Inclusion Criteria:\n\n* Healthy male or female adults aged 25-60 years.\n* Body mass index (BMI) between 18.5 and 24.9 kg\u002Fm².\n* Able and willing to provide written informed consent.\n* Willing and able to comply with all study procedures and scheduled visits\n\nExclusion Criteria:\n\n* History of diseases affecting the immune system or metabolism, including cardiovascular disease, diabetes mellitus, liver disease, kidney disease, autoimmune disorders, or chronic inflammatory diseases.\n* Abnormal laboratory findings outside the reference range, including complete blood count, liver function tests, or renal function tests.\n* Current use of medications or dietary supplements that may affect the study outcomes.\n* Known allergy to Spirulina, algae-containing dietary supplements, or any component of the study capsules.\n* Pregnant or breastfeeding women.",true,"ALL","25 Years","60 Years",{"count":75,"type":76},54,"ESTIMATED","INTERVENTIONAL",[79],"NA","This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the safety and immunomodulatory effects of Spirulina Blue Protein capsules in healthy adults. Participants will be randomly assigned to receive placebo, 200 mg\u002Fday, or 1,000 mg\u002Fday of Spirulina Blue Protein capsules for 12 weeks. The study will assess changes in immune cell populations (CD4+, CD8+, and natural killer cells), circulating cytokine levels, hematological and biochemical parameters, and the occurrence of adverse events. The findings will provide evidence regarding the safety and potential immunomodulatory benefits of Spirulina Blue Protein supplementation in healthy individuals and support the development of evidence-based functional food and nutraceutical products.",[82,83],"Healthy Volunteers","Immune System",[85,86,82,87],"Immunomodulation","Spirulina Blue Protein","Immune Function","2026-07-24",{"date":90,"type":91},"2026-07-29","ACTUAL",{"date":93,"type":76},"2026-08-15",{"date":95,"type":76},"2026-12-31",{"name":5,"class":6},1]